Long-term follow-up tracks benefits and risks of stem cell transplants for severe systemic sclerosis
An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation, adding evidence of sustained positive clinical outcomes and long-term safety in patients treated for early severe systemic sclerosis.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Many women have never discussed heart health with a clinician, and most report multiple symptoms
United Kingdom
-
The parts of fruits and vegetables most throw away could save your health—and the planet
United Kingdom
-
Worried nuts will cause weight gain? A large review puts that concern in perspective
United Kingdom
-
Can broccoli sprouts help with insulin resistance? New review offers clues
United Kingdom
-
Could a few bad dietary choices worsen your next immune response?
United Kingdom
-
Fish, shellfish or seaweed? A Korean study found striking differences in chemical exposure
United Kingdom
-
Noninvasive tests detect advanced liver scarring and could reduce reliance on biopsies
United Kingdom
-
How common dietary fats can aggravate chronic itch
United Kingdom